Effects of composite antimicrobial peptides in weanling piglets challenged with deoxynivalenol: II. Intestinal morphology and function

J Anim Sci. 2013 Oct;91(10):4750-6. doi: 10.2527/jas.2013-6427. Epub 2013 Aug 21.

Abstract

Deoxynivalenol (DON) affects animal and human health and targets the gastrointestinal tract. The objective of this study was to evaluate the ability of composite antimicrobial peptides (CAP) to repair intestinal injury in piglets challenged with DON. A total of 28 piglets (Duroc × Landrace × Large Yorkshire) weaned at 28 d of age were randomly assigned to receive 1 of 4 treatments (7 pigs/treatment): negative control, basal diet (NC), basal diet + 0.4% composite antimicrobial peptide (CAP), basal diet + 4 mg/kg DON (DON), and basal diet + 4 mg/kg DON + 0.4% CAP (DON + CAP). After an adaptation period of 7 d, blood samples were collected on d 15 and 30 after the initiation of treatment for determinations of the concentrations of D-lactate and diamine oxidase. At the end of the study, all piglets were slaughtered to obtain small intestines for the determination of intestinal morphology, epithelial cell proliferation, and protein expression in the mammalian target of rapamycin (mTOR) signaling pathway. The results showed that DON increased serum concentrations of D-lactate and diamine oxidase, and these values in the CAP and DON + CAP treatments were less than those in the NC and DON treatments, respectively (P < 0.05). The villous height/crypt depth in the jejunum and ileum and the goblet cell number in the ileum in the CAP and DON + CAP treatments were greater than those in the NC and DON treatments (P < 0.05). The proliferating cell nuclear antigen (PCNA) labeling indexes for the jejunum and ileum in the DON + CAP treatment were greater than those in the DON treatment (P < 0.05). The DON decreased (P < 0.05) the relative protein expression of phosphorylated Akt (Protein Kinase B) and mTOR in the jejunal and ileal mucosa and of phosphorylated 4E-binding protein 1 (p-4EBP1) in the jejunal mucosa, whereas CAP increased (P < 0.05) the protein expression of p-4EBP1 in the jejunum. These findings showed that DON could enhance intestinal permeability, damage villi, cause epithelial cell apoptosis, and inhibit protein synthesis, whereas CAP improved intestinal morphology and promoted intestinal epithelial cell proliferation and protein synthesis, indicating that CAP may repair the intestinal injury induced by DON.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amine Oxidase (Copper-Containing) / metabolism
  • Animals
  • Antimicrobial Cationic Peptides / administration & dosage
  • Antimicrobial Cationic Peptides / pharmacology*
  • Antioxidants / metabolism
  • Gallbladder / anatomy & histology
  • Gallbladder / drug effects
  • Heart / anatomy & histology
  • Heart / drug effects
  • Intestines / drug effects*
  • Intestines / pathology*
  • Intestines / physiology
  • Kidney / anatomy & histology
  • Kidney / drug effects
  • Liver / anatomy & histology
  • Liver / drug effects
  • Organ Size
  • Pancreas / anatomy & histology
  • Pancreas / drug effects
  • Spleen / anatomy & histology
  • Spleen / drug effects
  • Swine*
  • Thymus Gland / anatomy & histology
  • Thymus Gland / drug effects
  • Trichothecenes / toxicity*
  • Weaning
  • Weight Gain

Substances

  • Antimicrobial Cationic Peptides
  • Antioxidants
  • Trichothecenes
  • Amine Oxidase (Copper-Containing)
  • deoxynivalenol